Literature DB >> 20717101

The nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolites.

Tsuyoshi Waku1, Takuma Shiraki, Takuji Oyama, Kanako Maebara, Rinna Nakamori, Kosuke Morikawa.   

Abstract

The nuclear receptor, peroxisome proliferator-activated receptor γ (PPARγ), recognizes various synthetic and endogenous ligands by the ligand-binding domain. Fatty-acid metabolites reportedly activate PPARγ through conformational changes of the Ω loop. Here, we report that serotonin metabolites act as endogenous agonists for PPARγ to regulate macrophage function and adipogenesis by directly binding to helix H12. A cyclooxygenase inhibitor, indomethacin, is a mimetic agonist of these metabolites. Crystallographic analyses revealed that an indole acetate functions as a common moiety for the recognition by the sub-pocket near helix H12. Intriguingly, a serotonin metabolite and a fatty-acid metabolite each bind to distinct sub-pockets, and the PPARγ antagonist, T0070907, blocked the fatty-acid agonism, but not that of the serotonin metabolites. Mutational analyses on receptor-mediated transcription and coactivator binding revealed that each metabolite individually uses coregulator and/or heterodimer interfaces in a ligand-type-specific manner. Furthermore, the inhibition of the serotonin metabolism reduced the expression of the endogenous PPARγ-target gene. Collectively, these results suggest a novel agonism, in which PPARγ functions as a multiple sensor in response to distinct metabolites.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20717101      PMCID: PMC2957204          DOI: 10.1038/emboj.2010.197

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  71 in total

Review 1.  Binding of ligands and activation of transcription by nuclear receptors.

Authors:  A C Steinmetz; J P Renaud; D Moras
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001

2.  Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.

Authors:  H E Xu; M H Lambert; V G Montana; K D Plunket; L B Moore; J L Collins; J A Oplinger; S A Kliewer; R T Gampe; D D McKee; J T Moore; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase.

Authors:  J T Huang; J S Welch; M Ricote; C J Binder; T M Willson; C Kelly; J L Witztum; C D Funk; D Conrad; C K Glass
Journal:  Nature       Date:  1999-07-22       Impact factor: 49.962

4.  Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase.

Authors:  C Vindis; M H Séguélas; S Lanier; A Parini; C Cambon
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

5.  A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

Authors:  J L Oberfield; J L Collins; C P Holmes; D M Goreham; J P Cooper; J E Cobb; J M Lenhard; E A Hull-Ryde; C P Mohr; S G Blanchard; D J Parks; L B Moore; J M Lehmann; K Plunket; A B Miller; M V Milburn; S A Kliewer; T M Willson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors.

Authors:  R T Gampe; V G Montana; M H Lambert; A B Miller; R K Bledsoe; M V Milburn; S A Kliewer; T M Willson; H E Xu
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

7.  Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells.

Authors:  E Fontana; J Boucher; L Marti; J M Lizcano; X Testar; A Zorzano; C Carpéné
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

8.  Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family.

Authors:  P Cronet; J F Petersen; R Folmer; N Blomberg; K Sjöblom; U Karlsson; E L Lindstedt; K Bamberg
Journal:  Structure       Date:  2001-08       Impact factor: 5.006

9.  Autoregulation of the human liver X receptor alpha promoter.

Authors:  B A Laffitte; S B Joseph; R Walczak; L Pei; D C Wilpitz; J L Collins; P Tontonoz
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs).

Authors:  S J Shiff; B Rigas
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

View more
  39 in total

1.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 2.  Endogenous ligands for nuclear receptors: digging deeper.

Authors:  Michael Schupp; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

3.  When Does Chemical Elaboration Induce a Ligand To Change Its Binding Mode?

Authors:  Shipra Malhotra; John Karanicolas
Journal:  J Med Chem       Date:  2016-12-16       Impact factor: 7.446

4.  Rifampicin-independent interactions between the pregnane X receptor ligand binding domain and peptide fragments of coactivator and corepressor proteins.

Authors:  Punya Navaratnarajah; Bridgett L Steele; Matthew R Redinbo; Nancy L Thompson
Journal:  Biochemistry       Date:  2011-12-20       Impact factor: 3.162

5.  5-hydroxytryptamine actions in adipocytes: involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation.

Authors:  Sandra Grès; Saioa Gomez-Zorita; Ana Gomez-Ruiz; Christian Carpéné
Journal:  J Neural Transm (Vienna)       Date:  2012-12-28       Impact factor: 3.575

6.  Nuclear Receptor Chemical Reporter Enables Domain-Specific Analysis of Ligands in Mammalian Cells.

Authors:  Taku Tsukidate; Qiang Li; Howard C Hang
Journal:  ACS Chem Biol       Date:  2020-09-10       Impact factor: 5.100

7.  Monoamine oxidase A (MAO-A): a signature marker of alternatively activated monocytes/macrophages.

Authors:  Martha K Cathcart; Ashish Bhattacharjee
Journal:  Inflamm Cell Signal       Date:  2014

8.  A second chance for a PPARγ targeted therapy?

Authors:  Andrew W Norris; Curt D Sigmund
Journal:  Circ Res       Date:  2012-01-06       Impact factor: 17.367

Review 9.  A structural perspective on nuclear receptors as targets of environmental compounds.

Authors:  Vanessa Delfosse; Albane le Maire; Patrick Balaguer; William Bourguet
Journal:  Acta Pharmacol Sin       Date:  2014-12-15       Impact factor: 6.150

Review 10.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.